The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner ; volume:4 ; number:1 ; day:1 ; month:12 ; year:2011 ; pages:1-10 ; date:12.2011
Journal of hematology & oncology ; 4, Heft 1 (1.12.2011), 1-10, 12.2011
- Creator
-
Martin, Shiloh M.
Churchill, Eric
McKnight, Hayes
Mahaffey, Christopher M.
Ma, Yunpeng
O'Donnell, Robert T.
Tuscano, Joseph M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-8722-4-49
- URN
-
urn:nbn:de:101:1-2021082320165858182595
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Martin, Shiloh M.
- Churchill, Eric
- McKnight, Hayes
- Mahaffey, Christopher M.
- Ma, Yunpeng
- O'Donnell, Robert T.
- Tuscano, Joseph M.
- SpringerLink (Online service)
Other Objects (12)
Monoclonal antibody therapy
A novel dual-epigenetic inhibitor enhances recombinant monoclonal antibody expression in CHO cells
Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy
Monoclonal antibody applications in travel medicine
Bortezomib
Dynamic optimization strategies for monoclonal antibody production
Monoclonal antibody humanness score and its applications
Fibronectin glomerulopathy with monoclonal gammopathy responding to bortezomib plus dexamethasone: a case report
A monoclonal antibody collection for C. difficile typing ?
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Quality-targeting dynamic optimization of monoclonal antibody production
Intensification of cell clarification in monoclonal antibody manufacturing
Monoclonal antibody therapy
A novel dual-epigenetic inhibitor enhances recombinant monoclonal antibody expression in CHO cells
Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy
Monoclonal antibody applications in travel medicine
Bortezomib
Dynamic optimization strategies for monoclonal antibody production
Monoclonal antibody humanness score and its applications
Fibronectin glomerulopathy with monoclonal gammopathy responding to bortezomib plus dexamethasone: a case report
A monoclonal antibody collection for C. difficile typing ?
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Quality-targeting dynamic optimization of monoclonal antibody production
Intensification of cell clarification in monoclonal antibody manufacturing
Monoclonal antibody therapy
A novel dual-epigenetic inhibitor enhances recombinant monoclonal antibody expression in CHO cells
Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy
Monoclonal antibody applications in travel medicine
Bortezomib
Dynamic optimization strategies for monoclonal antibody production
Monoclonal antibody humanness score and its applications
Fibronectin glomerulopathy with monoclonal gammopathy responding to bortezomib plus dexamethasone: a case report
A monoclonal antibody collection for C. difficile typing ?
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Quality-targeting dynamic optimization of monoclonal antibody production